A potential role for the FGF system in depression and antidepressant action was indicated by microarray gene expression analysis of postmortem frontal cortex brain tissue from major depressive disorder (MDD) patients, showing dysregulation of multiple FGF transcripts and a reduction in FGF2 (Evans et al., 2004). Here, FGF2 is linked to depressive symptom measurement.